Ref | Species | Sample size | Exposure | Detection technique | Main findings | |||
---|---|---|---|---|---|---|---|---|
Particle type/coating or label | Size (nm) | Dose/ perfusion duration | (Semi-) Quantitative | Qualitative | ||||
 [37] | Human | 6 | Ag NPs/ carboxyl or PEG | 2–15 or 5–15b | 40 or 75 μg/mLc/ 6 h | spICP-MS | Bright-field light microscopy | Higher transplacental transport for smaller and PEGylated Ag NPs, while carboxylated Ag NPs accumulated more in placental tissue. |
 [31] | Human | 6 | Au NPs/ carboxyl or PEG | 3.5 ± 1.2 or 4.5 ± 1.5b | 25 μg/mLc/ 6 h | LA- and SF-ICP-MS | / | Only PEGylated Au NPs observed in the fetal circulation. Placental tissue accumulation similar for both Au NP types. |
 [38] | Rat | 11 | Au NPs | 20a | 5.8 μg/mLd/ 3 h | ICP-MS | Hyper-spectral microscopy imaging | Au NPs translocated across the rat placenta within 20 min of maternal infusion. |
 [23] | Human | n.d. | Au NPs/ PEG | 15 or 30a | 1.6 × 1011 or 1.6 × 1010 particles/mLd/ 18 min | ICP-MS | TEM and bright-field light microscopy | No placental transfer of Au NPs detected. Visual confirmation of localization of NPs in syncytiotrophoblasts. |
 [23] | Human | n.d. | Au NPs/ PEG | 10 or 15a | 9.1 × 109 or 2.0 × 109 particles/mLc/ 6 h | ICP-MS | TEM and bright-field light microscopy | No transfer of Au NPs across placenta regardless of NP size. Visual confirmation of placental tissue uptake of Au NPs. |
 [25] | Human | 6 | SiO2 NPs/ fluorophore | 25 or 50a | 100 μg/mLc/ 6 h | Fluorescence microscopy | Confocal microscopy | Limited transfer of both SiO2 NP sizes to fetal perfusate despite placental accumulation. |
 [39] | Human | n.d. | Magnetic NPs/ starch or PEI | 100 or 150a | 50 μg/mLc/ 6 h | Magnetic system | Bright-field light microscopy | Limited transfer of magnetic NPs from the maternal to the fetal circuit. Histological findings confirmed the presence of NPs in placental tissue. |
 [34] | Human | 6 | TiO2 NPs/ amine or carboxyl | 4 to 8a | 10 μg/mLc/ 6 h | SF-ICP-MS | / | No translocation of both TiO2 NP types to the fetal circulation but accumulation in placental tissue. |
 [40] | Human | 7 | PS NPs/ fluorophore | 80 or 500a | 25 μg/mLc/ 6 h | Fluorescence microscopy | / | 80 nm PS NPs able to cross the placenta, while 500 nm PS NPs retained in the placenta or maternal circuit. |
 [41] | Human | 12 | PS NPs/ fluorophore and carboxyl | 43.7 ± 8, 44.1 ± 7.1, 220.5 ± 5.1, or 289.4 ± 10.2b | 25 μg/mLe/ 6 h | Fluorescence microscopy | TEM | Increased translocation of plain compared to carboxylated PS NPs after 6 h of perfusion. Significantly higher transfer of NPs in the fetal to maternal direction observed with bidirectional transfer studies. Placental accumulation of all NPs regardless of modification and perfusion direction. |
 [42] | Human | 32 | PS NPs/ fluorophore, amine, or carboxyl | 63 ± 10, 71 ± 11, 78 ± 20, 88 ± 7, 89 ± 3, 181 ± 11, 224 ± 17, 455 ± 32, 451 ± 28, 494 ± 29, or 499 ± 8b | 25 μg/mLc/ 6 h | Fluorescence microscopy | / | Plain and small carboxylated PS NPs but not aminylated PS NPs transferred across the placenta after 6 h of perfusion. |
 [43] | Human | 16 | PS NPs/ fluorophore | 50, 80, 240, or 500a | 25 μg/mLc/ 6 h | / | TEM | PS NPs up to 240 nm crossed the placenta and reached the fetal circuit. 500 nm PS NPs mainly retained in the placental tissue and maternal circuit. |